163 related articles for article (PubMed ID: 38148059)
21. Olipudase alfa enzyme replacement therapy for acid sphingomyelinase deficiency (ASMD): sustained improvements in clinical outcomes after 6.5 years of treatment in adults.
Lachmann RH; Diaz GA; Wasserstein MP; Armstrong NM; Yarramaneni A; Kim Y; Kumar M
Orphanet J Rare Dis; 2023 Apr; 18(1):94. PubMed ID: 37098529
[TBL] [Abstract][Full Text] [Related]
22. SMPD1 expression profile and mutation landscape help decipher genotype-phenotype association and precision diagnosis for acid sphingomyelinase deficiency.
Wang R; Qin Z; Huang L; Luo H; Peng H; Zhou X; Zhao Z; Liu M; Yang P; Shi T
Hereditas; 2023 Mar; 160(1):11. PubMed ID: 36907956
[TBL] [Abstract][Full Text] [Related]
23. [Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases].
Lidove O; Belmatoug N; Froissart R; Lavigne C; Durieu I; Mazodier K; Serratrice C; Douillard C; Goizet C; Cathebras P; Besson G; Amoura Z; Tazi A; Gatfossé M; Rivière S; Sené T; Vanier MT; Ziza JM
Rev Med Interne; 2017 May; 38(5):291-299. PubMed ID: 27884455
[TBL] [Abstract][Full Text] [Related]
24. Acid Sphingomyelinase Deficiency: Sharing Experience of Disease Monitoring and Severity in France.
Mauhin W; Borie R; Dalbies F; Douillard C; Guffon N; Lavigne C; Lidove O; Brassier A
J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207195
[TBL] [Abstract][Full Text] [Related]
25. Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trial.
Wasserstein MP; Lachmann R; Hollak C; Barbato A; Gallagher RC; Giugliani R; Guelbert NB; Hennermann JB; Ikezoe T; Lidove O; Mabe P; Mengel E; Scarpa M; Senates E; Tchan M; Villarrubia J; Thurberg BL; Yarramaneni A; Armstrong NM; Kim Y; Kumar M
Orphanet J Rare Dis; 2023 Dec; 18(1):378. PubMed ID: 38042851
[TBL] [Abstract][Full Text] [Related]
26. Real-life impacts of olipudase alfa: The experience of patients and families taking an enzyme replacement therapy for acid sphingomyelinase deficiency.
Raebel EM; Wiseman S; Donnelly C; Mathieson T; Pountney J; Crowe J; Hopkin J
Orphanet J Rare Dis; 2024 Feb; 19(1):36. PubMed ID: 38303068
[TBL] [Abstract][Full Text] [Related]
27. Deep sequencing of SMPD1 gene revealed a heterozygous frameshift mutation (p.Ser192Alafs) in a Palestinian infant with Niemann-Pick disease type A: a case report.
Nasereddin A; Ereqat S
J Med Case Rep; 2018 Sep; 12(1):272. PubMed ID: 30223864
[TBL] [Abstract][Full Text] [Related]
28. Functional characterization of novel variants in SMPD1 in Indian patients with acid sphingomyelinase deficiency.
Deshpande D; Gupta SK; Sarma AS; Ranganath P; Jain S JMN; Sheth J; Mistri M; Gupta N; Kabra M; Phadke SR; Girisha KM; Dua Puri R; Aggarwal S; Datar C; Mandal K; Tilak P; Muranjan M; Bijarnia-Mahay S; Rama Devi A R; Tayade NB; Ranjan A; Dalal AB
Hum Mutat; 2021 Oct; 42(10):1336-1350. PubMed ID: 34273913
[TBL] [Abstract][Full Text] [Related]
29. Acid Sphingomyelinase Deficiency: A Clinical and Immunological Perspective.
Pinto C; Sousa D; Ghilas V; Dardis A; Scarpa M; Macedo MF
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884674
[TBL] [Abstract][Full Text] [Related]
30. Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.
Eskes ECB; van der Lienden MJC; Sjouke B; van Vliet L; Brands MMMG; Hollak CEM; Aerts JMFG
Mol Genet Metab; 2023 Aug; 139(4):107631. PubMed ID: 37453187
[TBL] [Abstract][Full Text] [Related]
31. Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective.
Pokrzywinski R; Hareendran A; Nalysnyk L; Cowie S; Crowe J; Hopkin J; Joshi D; Pulikottil-Jacob R
Sci Rep; 2021 Oct; 11(1):20972. PubMed ID: 34697402
[TBL] [Abstract][Full Text] [Related]
32. R542X mutation in SMPD1 gene: genetically novel mutation with phenotypic features intermediate between type A and type B Niemann-Pick disease.
Aneja A; Sharma A; Dalal A; Sondhi V
BMJ Case Rep; 2012 Nov; 2012():. PubMed ID: 23188845
[TBL] [Abstract][Full Text] [Related]
33. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
34. Long-term safety and clinical outcomes of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency: two-year results.
Diaz GA; Giugliani R; Guffon N; Jones SA; Mengel E; Scarpa M; Witters P; Yarramaneni A; Li J; Armstrong NM; Kim Y; Ortemann-Renon C; Kumar M
Orphanet J Rare Dis; 2022 Dec; 17(1):437. PubMed ID: 36517856
[TBL] [Abstract][Full Text] [Related]
35. Interstitial lung disease in lysosomal storage disorders.
Borie R; Crestani B; Guyard A; Lidove O
Eur Respir Rev; 2021 Jun; 30(160):. PubMed ID: 33927007
[TBL] [Abstract][Full Text] [Related]
36. Acid Sphingomyelinase Deficiency Type B Patient-Derived Liver Organoids Reveals Altered Lysosomal Gene Expression and Lipid Homeostasis.
Gomez-Mariano G; Perez-Luz S; Ramos-Del Saz S; Matamala N; Hernandez-SanMiguel E; Fernandez-Prieto M; Gil-Martin S; Justo I; Marcacuzco A; Martinez-Delgado B
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628828
[TBL] [Abstract][Full Text] [Related]
37. Plasma lyso-sphingomyelin levels are positively associated with clinical severity in acid sphingomyelinase deficiency.
Breilyn MS; Zhang W; Yu C; Wasserstein MP
Mol Genet Metab Rep; 2021 Sep; 28():100780. PubMed ID: 34285875
[TBL] [Abstract][Full Text] [Related]
38. Health insurance literacy and health services access barriers in Niemann-Pick disease: the patient and caregiver voice.
Diaz GA; Crowe J; Hopkin J
Orphanet J Rare Dis; 2022 Sep; 17(1):332. PubMed ID: 36056366
[TBL] [Abstract][Full Text] [Related]
39. Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency.
Wasserstein MP; Jones SA; Soran H; Diaz GA; Lippa N; Thurberg BL; Culm-Merdek K; Shamiyeh E; Inguilizian H; Cox GF; Puga AC
Mol Genet Metab; 2015; 116(1-2):88-97. PubMed ID: 26049896
[TBL] [Abstract][Full Text] [Related]
40. Altered Macrophage Function Associated with Crystalline Lung Inflammation in Acid Sphingomyelinase Deficiency.
Poczobutt JM; Mikosz AM; Poirier C; Beatman EL; Serban KA; Gally F; Cao D; McCubbrey AL; Cornell CF; Schweitzer KS; Berdyshev EV; Bronova IA; Paris F; Petrache I
Am J Respir Cell Mol Biol; 2021 May; 64(5):629-640. PubMed ID: 33662226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
